PERSPECTA

News from every angle

← Back to headlines

H.C. Wainwright Reduces Price Goal on Summit Therapeutics Inc.

H.C. Wainwright has lowered its price target for Summit Therapeutics Inc. (SMMT) stock.

13 May, 17:53 — 13 May, 17:53
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual115d ago

H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT)

Read full article →

Related Stories

French Prosecutors Seize €65 Million From McKinsey in Tax Fraud Probe

1d ago

Dangote Refinery Secures Approval for $1.5 Billion IPO

1d ago

US Diesel Prices Hit Record High Amid Global Supply Strains

1d ago

India’s Foreign Exchange Reserves Reach Record $740.8 Billion

1d ago